Pfizer gets three-year reprieve from planned tariffs, as it agrees to lower drug prices for Americans
Trump announced a landmark deal with Pfizer granting the company a three-year reprieve from planned tariffs in exchange for voluntarily lowering US drug prices. Pfizer will offer most-favored-nation pricing for Medicaid and all new drugs, participate in the TrumpRx direct-to-consumer platform
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
